Quentin S. Blackford
President, CEO & DirectorMr. Quentin S. Blackford is Independent Director of Align Technology, Inc. from August 31, 2026. He is Non-Executive Director of Saluda Medical Pty Ltd. He is Independent Non-Executive Director of Saluda Medical, Inc since December 01, 2025. Mr. Blackford is Director of Alphatec Spine, Inc. Mr. Blackford was Independent Director of Alphatec Spine, Inc. from October 2017. Mr. Blackford joined the Alphatec Spine, Inc. on October 02, 2017. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhythm Holdings, Inc. (formerly known as iRhythm Technologies, Inc.) since 2022. He served as Chief Operating Officer at DexCom, Inc. since October 1, 2019 until September 17, 2021. He had been Chief Financial Officer of DexCom, Inc. since September 01, 2017 until March 2021 and was its Executive Vice President until 2020. Mr. Blackford joined DexCom in August 2017. He has been an Independent Director of Alphatec Holdings, Inc. since October 2, 2017. Mr. Blackford had been Director of AxoGen, Inc. since May 15, 2019 until March 30, 2022. Mr. Blackford served as Chief Financial Officer of NuVasive, Inc. from August 1, 2014 to August 25, 2017 and served as its Executive Vice President from August 2014 to August 25, 2016. Mr. Blackford served as the Head of Strategy & Corporate Integrity at NuVasive, Inc. from August 2016 to August 25, 2017. He served as Chief Accounting Officer of NuVasive, Inc. from August 1, 2014 to August 1, 2016. He served as Executive Vice President of Finance & Investor Relations at NuVasive, Inc. from January 2011 to June 2012. Mr. Blackford served as Senior Vice President of Finance & Investor Relations at NuVasive, Inc. since July 2012. Mr. Blackford served as Senior Vice President of Finance & Treasury at NuVasive, Inc. since July 2012. Mr. Blackford served as Vice President of Finance at NuVasive, Inc. from January 2011 to June 2012. Mr. Blackford served at Zimmer Biomet, Inc. Mr. Blackford joined NuVasive in 2009 as Corporate Controller. Prior to his roles at NuVasive, Mr. Blackford led the global financial planning & analysis group at Zimmer Table of Contents 4 Holdings, Inc. Mr. Blackford was responsible for leading NuVasive's Finance, Strategy & Corporate Development, Compliance and Regulatory functions. He has experience in the healthcare industry. From June 1999 to September 2009, Mr. Blackford held various roles at Zimmer Holdings, Inc., the most recent one as the Director of Finance and Controller of the Dental Division at Zimmer Holdings, Inc., a medical device company. He was responsible for all finance, accounting and IT activities for the worldwide division. He has experience in the Medical Device Industry. Mr. Blackford is a Certified Public Accountant. Mr. Blackford has B.S. in Business Administration, Accounting from Grace Schools, Inc.
Positions
- Company NameiRhythm Holdings, Inc.Stock CodeIRTCPositionPresident, CEO & DirectorColleagues
- AYAbhijit Y. TalwalkarIndependent Chairman
- DGDaniel G. WilsonCFO & Principal Financial Officer
- MPMinang P. TurakhiaChief Medical & Scientific Officer and Executive VP of Advanced Technologies
- PMPatrick Michael MurphyChief Business & Legal Officer
- CMChad M. PattersonChief Commercial and Product Officer
- BGBruce George BodakenIndependent Director
- KLKaren L. LingIndependent Director
- KKKaren K. McGinnisIndependent Director
